The strongest pain reliever available in clinical medicine is sufentanil, a synthetic opioid roughly 7.5 times more potent than fentanyl and thousands of times more potent than morphine. But “strongest” depends entirely on context. The most powerful drug isn’t always the most effective one for a given type of pain, and for many common pain problems, non-opioid options actually perform better than you’d expect.
How Opioid Potency Is Measured
Pain medications are compared using a standard unit called oral morphine equivalents (OME). Morphine taken by mouth is the baseline: 1 milligram of oral morphine equals 1 OME. Every other opioid is measured against it. A single microgram of intravenous sufentanil, for example, equals 3 milligrams of oral morphine. That means a tiny dose measured in millionths of a gram delivers the same pain relief as a much larger dose of morphine. Intravenous fentanyl is roughly 100 times more potent than oral morphine, and sufentanil is about 7.5 times more potent than fentanyl, based on equianalgesic infusion studies in chronic pain patients.
Hydromorphone, another commonly used opioid, falls in between. Taken by mouth, it’s about 5 times stronger than morphine milligram for milligram. Given intravenously, it’s about 18 times stronger. These drugs exist on a spectrum, and the route they’re given (IV, oral, patch, spinal) dramatically changes their effective potency. Fentanyl delivered directly into the spinal fluid, for instance, has a multiplication factor of 3,750 compared to oral morphine.
Why the “Strongest” Isn’t Always the Best
Potency and effectiveness are not the same thing. A more potent drug simply means you need a smaller dose to achieve the same effect. It doesn’t mean the pain relief ceiling is higher or the experience is better. All full opioid agonists can theoretically relieve the same amount of pain if dosed high enough, but higher doses bring exponentially more risk. The CDC’s prescribing guideline notes that once a patient reaches 50 OME per day, the risks of overdose and death rise continuously, while the additional pain relief from further increases diminishes. In other words, cranking up the dose stops working well before it stops being dangerous.
Opioids also carry well-known side effects. In one surgical study comparing morphine delivered through a patient-controlled pump to a non-opioid alternative, 79% of patients on morphine experienced complications like nausea, vomiting, or urinary retention, compared to 20% in the non-opioid group.
Over-the-Counter Options Are Stronger Than Most People Think
For many types of acute pain, including dental pain, headaches, sprains, and minor injuries, over-the-counter medications can match or outperform prescription opioids. The key metric here is the “number needed to treat” (NNT), which tells you how many people need to take a drug for one person to get at least 50% pain relief within four to six hours. Lower is better.
Naproxen (the active ingredient in Aleve) has an NNT of 2.7, meaning roughly one in three people who take it gets meaningful relief. But the real standout is the combination of ibuprofen 200 mg plus acetaminophen 500 mg, which has an NNT of just 1.6. That’s better than many opioid formulations for acute pain. This combination works because the two drugs target different pain pathways: ibuprofen reduces inflammation, while acetaminophen acts centrally in the brain.
Acetaminophen on its own is the usual first recommendation for mild to moderate pain. The FDA sets the maximum daily dose at 4,000 milligrams across all sources, including combination products. Going over that threshold risks serious liver damage, especially if alcohol is involved.
Nerve Pain Needs Different Drugs Entirely
Standard pain relievers, including opioids, often perform poorly against nerve pain caused by conditions like diabetes, shingles, or spinal nerve compression. For this type of pain, medications originally designed for seizures or depression tend to work better. Pregabalin, for instance, achieves a 50% pain reduction in diabetic neuropathy with an NNT of 4 at its highest dose. In a head-to-head trial involving cancer-related nerve pain, pregabalin produced lower pain scores than gabapentin, amitriptyline (an older antidepressant), or placebo.
This is one of the most important things to understand about pain relief: the “strongest” medication depends on what’s generating the pain. Opioids overwhelm the brain’s pain processing, which makes them excellent for acute trauma and surgical recovery. But for a nerve that’s misfiring, you need a drug that calms the nerve itself.
Combining Medications Outperforms Single Drugs
Modern pain management increasingly relies on combining drugs from different classes rather than pushing one drug to its maximum dose. This approach, called multimodal analgesia, targets multiple pain pathways at once and produces synergistic effects. A large analysis of post-surgical patients found that combining an anti-inflammatory with a steroid (dexamethasone) reduced opioid use by an average of nearly 30 OMEs and produced the greatest pain reductions among inpatients. For outpatients, dexamethasone combined with either a nerve block or ketamine delivered the best results.
The practical takeaway is significant. Rather than relying on a single powerful opioid, layering two or three different types of pain relief together often produces better results with fewer side effects. This is why surgical teams now routinely give patients acetaminophen, an anti-inflammatory, and sometimes a nerve block before or during surgery, reserving opioids for breakthrough pain.
When Opioids Are the Right Call
Opioids remain the appropriate choice for severe acute pain from major trauma, surgery, or active cancer treatment. After an operation, they’re highly effective for short-term use. For chronic non-cancer pain, they’re considered a last resort after other options have failed. The CDC guideline recommends starting at the lowest effective dose, typically 20 to 30 OME per day, using immediate-release formulations rather than extended-release versions. Extended-release opioids are reserved for patients with severe, continuous pain who have already been taking daily opioids for at least a week.
The strongest opioids like sufentanil and fentanyl are used almost exclusively in controlled medical settings: operating rooms, intensive care units, and supervised infusion clinics. They’re not prescribed as take-home pills. For outpatient use, the strongest commonly prescribed opioids are extended-release formulations of hydromorphone and oxycodone, which provide steady pain relief over 12 to 24 hours for patients with severe chronic pain.

